The synthesis of spiro[indole-3,1'-pyrrolo[3,4 -c]pyrrole]-2,4',6'-trione derivatives, the study of their antimicrobial activity and the molecular docking on staphylococcal dehydrosqualene synthase Aim. To synthesize the series of new spiro [indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,4',6'-trione derivatives, study their physicochemical characteristics, antibacterial activity and precision of the molecular docking on the model of staphylococcal dehydrosqualene synthase.
The widespread use of β-lactam antibiotics in the twentieth century, in particular penicillin, led to formation of staphylococcal resistance due to mutations in virulence factors (β-lactamase, staphylokinase, exfoliatin, and others). To combat staphylococcal infections currently methicillin is used, in respect of which resistant strains are also recorded, which even appears in the division of strains of S. aureus into methicillin-sensitive and methicillin-resistant (MRSA), as well as more resistant to vancomycin-resistant (VRSA) and glycopeptide-resistant (GISA). Among patients infected with methicillin-resistant strains mortality is 31 % [1] . Therefore, the search for new chemotherapeutic agents, in particular with the anti-staphylococcal activity, is one of the urgent tasks of modern pharmaceutical science.
It is known that an important factor of virulence is the carotenoid pigment -stafiloxanthin in S. aureus cells [2] . This pigment acts as a powerful antioxidant with its nine conjugated double bonds, which allow to neutralize the reactive forms of oxygen [3] . The S. aureus bacteria without the carotenoid pigment die quickly. Thus, blocking of the stafiloxanthin biosynthesis is potentially attractive to the new therapeutic target to which resistance mechanisms have not been formed [4, 5] . The initial phase of stafiloxanthin synthesis is carried by the key enzymedehydrosqualene synthase (CrtM), which catalyzes the "head to head" condensation of two molecules of farnesyl pyrophosphate (FPP) in C 30 carotenoid dehydrosqualene (4,4'-diapofitohen) [6] .
Our attention was drawn to the derivatives of bisspiro[indole-3,1'-pyrrolo [3,4-c] pyrrole synthesized for the first time as a promising antimicrobial agents; they appeared to have a significant antibacterial potential [7] . Spiro-2-oxindoles are widely represented in nature as hemiterpenic alkaloids -elakomin, chorsfillin, cerulusin from plants of the genus Poaceae sp., antibioticsparagerquamides and notamides from fungi of Penicillium sp. species, phytoncides from the genus Brassicaceae sp. [8] , but spiro-2-oxindoles with a double spiro [indole-3,1'-pyrrolo [3,4-c] pyrrole] fragment are unknown in nature.
In this paper, we tried to consider the bis derivatives of spiro-2-oxindole synthesized as potent inhibitors of CrtM. The key idea of the design of new chemotherapeutic agents based on the spirocyc, non-planar synthetic platform is the possibility of introducing additional aliphatic substituents into new molecules located in the regions of the substrate-binding pocket of microbial cell enzymes. The applied "drug-design" approach by constructing a bis-fragment corresponds to the principle of the so-called "hybrid" or "double-drugs" first used successfully in the search for new antimalarial [9] and anti-HIV agents [10] .
Materials and methods

Chemical part
All solvents and reagents were obtained from commercial sources. The 1 H, 13 C NMR-spectra were recorded on a Bruker Avance 170500 spectrometer at 500 MHz for 1 H-NMR-spectra; the solvent was DMSOd 6 ; tetrametylsilan (TMS) was used as an internal standard for 1 H, 13 C. LC-MS were recorded using an Agilent 1100 HPLC device equipped with a diode array detector and mass spectrometer (Agilent LC-MSD SL); the column was Zorbax SB-C 18 (4.6 × 15 mm) with the chemical ionization atmospheric pressure (APCI); for analysis TLC was performed on Silufol UV-254 aluminum plates in the solvent system of dichloromethane: methanol (9 : 1). The melting point was measured by Kofler device.
The were obtained according to the onepot method described earlier [7] .
The general procedure for the synthesis of 1-R 1 -3'-R 2 -5 '(6-N-maleimido-hexyl)-3'a,6'a-dihydro-3'Hspiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,4',6'-triones (5.1-5.10) was described in our previous paper [11] . Cool the solution and dilute with 50 ml of water, then extract with dichloromethane (3 × 20 ml), wash with water (100 ml), dry the resulting extract over magnesium sulfate and purify by column chromatography with 0.2-0.5 mm silica gel with the particle size of 40 Å (EMD Millipore ® , 10181) in the dichloromethane : methanol (9 : 1) system.
Microbiological Experiment
The antimicrobial activity of drugs was studied in vitro commonly accepted in microbiological practice by the agar diffusion test in the "modification of wells" [12] .
The molten agar nutrient medium was cooled to 45 o C, poured into the bottom layer in Petri dishes in the volume of 10 ml. After freezing agar six sterile cylinders of stainless steel with the height of 10 mm and the internal diameter of 8 mm were placed on it, around them the second layer was poured in the volume of 15 ml, and seeded with appropriate cultures of microorganisms. The microbial load was 500 thousand microbial cells per 1 ml of the dense nutrient medium. After clamping the top layer of agar on Petri dishes the cylinders were removed with sterile tweezers, and the drug was introduced into the wells formed. Preparation of samples of the substances. The accurate weight of each compound (1 mg) was thoroughly mixed with the solvent (1 ml) according to the rules of aseptics in sterile glass tubes. From the resulting suspension of the drug, 0.3 ml was taken and put into cubes on Petri dishes with microbial cultures. Petri dishes were kept for one hour at room temperature, then placed in a thermostat and incubated for 24 h at 37 o C with the meat-peptone agar and at 25 o C for 48 h with Candida albicans agar.
The level of the antimicrobial activity of the substances was recorded with the diameter of the growth inhibition zone of microorganisms around the well with the drug, and assessed compared to controls (the solvent and reference preparation).
The second phase of our research was to study the antimicrobial activity of drugs in relation to the cultures of Staphylococcus aureus ATCC 25923 and Candida albicans ATCC 885-653 by two-fold serial dilutions in a liquid nutrient medium. The meat-peptone broth and Saburro broth were poured into 1 ml test tubes placed in a tray of 10 test tubes in row. Into the first test tube 1 ml of the chemotherapeutic solution in the concentration of (200 μg/ml) was introduced. After thorough mixing 1 ml from this test tube was transferred to the second one, mixed, then the quantity of the mixture from the second test tube was transferred to the third one, etc. In the ninth tube, from which 1 ml was poured out in all the test tubes, the volume of the liquid was identical. The tenth test-tube without the substances studied served as the control over the microorganism's culture growth. Subsequently, all test tubes containing the serially diluted drug and the same amount of the test-culture suspension were added to the control tube. For this, a 18-hour culture (Staphylococcus aureus ATCC 25923) and a 2-hour culture (Candida albicans ATCC 885-653) of the microbe tested on the oblique agar were washed with the saline solution, adjusted to a density of 5 OU according to the standard of turbidity, followed by dilution to the desired amount of microbial cells in 1 ml and were introduced into test tubes with a serially diluted drug. The results were taken into account, determining the presence or absence of the microbe growth in the medium containing various breeding chemotherapy. The last growth retort (a transparent broth) corresponded to the drug MIC in relation to the strain tested and indicated the degree of its sensitivity. If the medium is turbid in all test tubes, then the microbe tested is resistant to the maximum concentration of chemotherapy that is taken in the test. The absence of growth in all test tubes, in addition to the control, indicates that MIC of the drug in relation to the microbe is lower than the concentration used.
To determine the bactericidal concentration (MBC) from 2-3 last samples with no apparent growth agar or broth cultures were used. After 24-48-72 hours of incubation in the thermostat the lowest concentration of the antibacterial chemotherapy in the test tube, which did not give rise to growth, was taken for MBC.
The molecular docking and screening in silico of the potential dehydrosqualene synthase of Staphylococcus aureus (PDB ID 2zcq) inhibitors.
The syllabus in silico consisted of four main steps: preparation of the library of compounds, docking, evaluation of the results and the procedure of filtering. The source of data on the structure of the complex enzymeinhibitor is Protein Data Bank (PDB). The crystalline structure of the enzyme and its ligand coordinated with two cations of the Mg 2+ ion exchanger of the bisphosphonate series -(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid were selected as the model of sta-
The code structure of the ligand-enzyme complex according to the X-Ray is PDB ID 2zcq, resolution 2.38 Å, R-factor = 0.223, R-free = 0.270 [5] . The simulation was carried out to the chain A, the length of the amino acid sequence was 293 amino acids, the molecular weight -34.79 KDa. The active center of the receptor was limited to a cube with a side of 2.38 Å, its location was determined by the coordinates of the ligand in the crystalline structure selected (X = 17.5902, Y = 52.3671, Z = 38.0749) for the construction of maps of energy potentials of atoms with an interval of 0.375 Е. For the docking process the Auto Dock Vina program integrated on the on-line molecule platform (http://doc.mcule.com/doku.php?id=dockingvina# docking_vina) with the Vina docking algorithm was used [13] . For the docking procedure charges of the receptor and ligand molecules were calculated using the GasteigerMarsil method [14] using the AutoDock Vina program. The search for the optimal geometry of complexes was carried out using a non-moving active center and flexible ligands. The mobility of the latter was determined by rotation around single bonds that were not part of the cycle. Further, the energy gain in formation of the corresponding complex (E Doc , kcal/mol) was calculatedthe free binding energy of the corresponding site CrtM at T = 298.15 K. For the 3D visualization the GLmol browser based on WebGL/Javascript (http://webglmol. osdn.jp/index-en.html) was used. When forming the posture the ligand was placed in the binding site, selecting its rotational and translational degrees of freedom. Subsequently, affinity was estimated on the basis of the prevailing posture. For each structure 4 attempts were made, and the most active position considered was the location of the ligand corresponding to the lowest energy (the highest gain in energy).
Results and discussion
In order to synthesize a new series of the target 1- 1-1.4, amino acids  2.1-2.11 and 1,6 -bis-maleimidohexane 3 were studied. For example, in the previous work we first described the synthesis of compounds of this class containing the bis-spirocyclic system, in which two cores of spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,4',6'-trione were linked by a 1,6-hexylidene radical [7] . Thus, the new bis-spiro derivaties 4.1-4.15 were synthesized according to the previous protocol when 1 mol of 1,6-bis-maleimidohexane was condensed with 2 Mol of the corresponding isatin and amino acids. When in the condensation with dipolarophile 3 the initial isatins (1.1, 1.3, 1.4) and amino acids (2.3, 2.6-2.11) were equilibrated, 1- The signals of aliphatic protons of the hexamethylene residue observed as a signal of CH 2 CH 2 groups, two multiplets at δ 0.83-1.29 and δ 1.11-1.75 ppm, and the signal of 5'-NCH 2 two fragments were present in the region from δ 2.53 up to 3.52 ppm.
In this paper the antimicrobial potential of bis-spiro compounds (4.1-4.15) and derivatives with the free 6-maleimido-hexyl radical (5.1-5.10) was compared. The antimicrobial activity of all compounds tested is present in Fig. 1-4 .
The results of the minimal bactericidal concentration (MBC) determination for the compounds tested are given in Tab. 2. Table 1 The (Fig. 1) .
The test culture of B.subtilis was sensitive and highly sensitive to most of the test substances, but none of them exceeded cefalexin by the diameter of the growth inhibition zones (Fig. 2) . Continuation of Table 1 The culture of E. coli was sensitive to compounds 5.7 and 5.8. While the gram-negative test culture of P. aeruginosa was not sensitive to all compounds studied, except cefalexin (36.0 ± 0.1 mm), since the growth inhibition zones of P. aeruginosa were less than the solvent control in the study of samples. Thus, according to the results of the tests the substances synthesized showed predominantly the activity Table 2 The MBC of the most active compounds selected Notes: * -the average value for the experiments; n/t -not tested; "-" bacteriostatic activity. active position in silico was not generated. It also correlates with the absence of the antistaphylococcal and antifungal activity in vitro.
The validation of binding of the control structure of BPH-65 to the amino acid residues of the active CrtM center after the results of the docking obtained by us in silico on the 3D CrtM model (Fig. 6 ) is close to the parameters of formation of the ligand-target complex obtained by the X-ray method for the co-crystal of the BPH-65 compound with the CrtM enzyme in the literature [5] .
In particular, as for location of the BPH-65 ligand in the X-ray experiment, the π-π contact of the phenyl radical Phe22 with a nucleus of the biphenyl residue of the ligand, hydrophobic interactions with Val133, Val137 and formation of hydrogen bonds with Arg45, Asp48, Gln165, Asn168, Asp172, and its -P(O)(OH) 2 and -SO 3 H polar residues reduced. Somewhat low docking energy when validating binding of the BPH-65 ligand to the target can be explained by neglect of the in silico experiment to coordinate the ligand with two Mg 2+ cations and water molecules. 
